Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
LLY.SW Stock Summary
Top 10 Correlated ETFs
LLY.SW
In the News
LLY.SW Financial details
Company Rating
Strong Buy
Market Cap
483.32B
Income
6.5B
Revenue
29.52B
Book val./share
12.3
Cash/share
3.14
Dividend
4.37
Dividend %
0.82%
Employees
39K
Optionable
No
Shortable
Yes
Earnings
02 Nov 2023
P/E
73.84
Forward P/E
46.18
PEG
36.61
P/S
17.15
P/B
43.36
P/C
156.05
P/FCF
157.63
Quick Ratio
0.63
Current Ratio
1.13
Debt / Equity
1.7
LT Debt / Equity
1.64
-
-
EPS (TTM)
7.03
EPS next Y
10.61
EPS next Q
-
EPS this Y
12.31%
EPS next Y
50.93%
EPS next 5Y
50.93%
EPS last 5Y
15.91%
Revenue last 5Y
5.84%
Revenue Q/Q
19.43%
EPS Q/Q
38.03%
-
-
-
-
SMA20
1.65%
SMA50
24.24%
SMA100
-
Inst Own
-
Inst Trans
-
ROA
12%
ROE
60%
ROC
0.21%
Gross Margin
78%
Oper. Margin
25%
Profit Margin
22%
Payout
59%
Shs Outstand
949.29M
Shs Float
897.49M
-
-
-
-
Target Price
-
52W Range
274.0-484.0
52W High
+1.24%
52W Low
+78.83%
RSI
79
Rel Volume
1016.69
Avg Volume
59
Volume
59.99K
Perf Week
-0.41%
Perf Month
2.94%
Perf Quarter
-
Perf Half Y
60.13%
-
-
-
-
Beta
0.315006
-
-
Volatility
0.7%, 4.89%
Prev Close
-0.41%
Price
490
Change
-0.41%
LLY.SW Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 20.91 | 23.31 | 25.65 | 29.69 | 30.04 | |
Net income per share | 3.14 | 4.84 | 6.47 | 5.85 | 6.57 | |
Operating cash flow per share | 5.38 | 5.05 | 6.79 | 7.61 | 7.46 | |
Free cash flow per share | 2.44 | 3.64 | 4.67 | 5.65 | 4.84 | |
Cash per share | 7.21 | 2.55 | 3.85 | 4.1 | 2.33 | |
Book value per share | 9.56 | 2.72 | 5.9 | 9.42 | 11.21 | |
Tangible book value per share | 8.25 | -7.94 | -5.64 | -2.55 | -0.53 | |
Share holders equity per share | 9.56 | 2.72 | 5.9 | 9.42 | 11.21 | |
Interest debt per share | 10.29 | 16.92 | 17.72 | 18.06 | 17.44 | |
Market cap | 116.36B | 110.56B | 159.34B | 242.14B | 357.68B | |
Enterprise value | 119.34B | 124.03B | 172.28B | 255.21B | 371.85B | |
P/E ratio | 36 | 23.84 | 25.73 | 43.38 | 57.28 | |
Price to sales ratio | 5.41 | 4.95 | 6.49 | 8.55 | 12.53 | |
POCF ratio | 21.06 | 22.86 | 24.52 | 33.35 | 50.49 | |
PFCF ratio | 46.43 | 31.74 | 35.64 | 44.95 | 77.75 | |
P/B Ratio | 11.84 | 42.41 | 28.24 | 26.97 | 33.59 | |
PTB ratio | 11.84 | 42.41 | 28.24 | 26.97 | 33.59 | |
EV to sales | 5.55 | 5.56 | 7.02 | 9.01 | 13.03 | |
Enterprise value over EBITDA | 12.37 | 18.78 | 22.55 | 29.2 | 39.42 | |
EV to operating cash flow | 21.6 | 25.64 | 26.51 | 35.15 | 52.49 | |
EV to free cash flow | 47.61 | 35.61 | 38.54 | 47.37 | 80.83 | |
Earnings yield | 0.03 | 0.04 | 0.04 | 0.02 | 0.02 | |
Free cash flow yield | 0.02 | 0.03 | 0.03 | 0.02 | 0.01 | |
Debt to equity | 1.05 | 6.06 | 2.94 | 1.88 | 1.52 | |
Debt to assets | 0.23 | 0.4 | 0.36 | 0.35 | 0.33 | |
Net debt to EBITDA | 0.31 | 2.04 | 1.69 | 1.5 | 1.5 | |
Current ratio | 1.73 | 1.16 | 1.4 | 1.23 | 1.05 | |
Interest coverage | 22.74 | 12.42 | 16.85 | 18.71 | 21.49 | |
Income quality | 1.71 | 0.58 | 1.05 | 1.3 | 1.13 | |
Dividend Yield | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | |
Payout ratio | 0.72 | 0.52 | 0.43 | 0.55 | 0.57 | |
Sales general and administrative to revenue | 0.28 | 0.28 | 0.25 | 0.23 | 0.23 | |
Research and developement to revenue | 0.24 | 0.25 | 0.25 | 0.25 | 0.25 | |
Intangibles to total assets | 0.06 | 0.26 | 0.24 | 0.24 | 0.23 | |
Capex to operating cash flow | -0.55 | -0.28 | -0.31 | -0.26 | -0.35 | |
Capex to revenue | -0.14 | -0.06 | -0.08 | -0.07 | -0.09 | |
Capex to depreciation | -1.88 | -1.1 | -1.53 | -1.21 | -1.63 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Graham number | 26.01 | 17.23 | 29.31 | 35.21 | 40.71 | |
ROIC | 0.26 | 0.23 | 0.23 | 0.22 | 0.24 | |
Return on tangible assets | 0.08 | 0.16 | 0.17 | 0.15 | 0.16 | |
Graham Net | -19.18 | -29.66 | -31.3 | -29.05 | -29.39 | |
Working capital | 8.66B | 1.93B | 4.98B | 3.4B | 896.3M | |
Tangible asset value | 8.47B | -7.6B | -5.39B | -2.43B | -504.2M | |
Net current asset value | -12.45B | -22.88B | -23.35B | -21.2B | -20.68B | |
Invested capital | 1.05 | 6.06 | 2.94 | 1.88 | 1.52 | |
Average receivables | 5.52B | 5.66B | 6.24B | 7.53B | 8.34B | |
Average payables | 1.31B | 1.31B | 1.51B | 1.64B | 1.8B | |
Average inventory | 3.78B | 3.14B | 3.59B | 3.93B | 4.1B | |
Days sales outstanding | 98.1 | 90.62 | 103.06 | 104.75 | 109.45 | |
Days payables outstanding | 94.11 | 108.64 | 106.95 | 83.38 | 106.29 | |
Days of inventory on hand | 241.54 | 246.68 | 264.95 | 193.96 | 237.27 | |
Receivables turnover | 3.72 | 4.03 | 3.54 | 3.48 | 3.33 | |
Payables turnover | 3.88 | 3.36 | 3.41 | 4.38 | 3.43 | |
Inventory turnover | 1.51 | 1.48 | 1.38 | 1.88 | 1.54 | |
ROE | 0.33 | 1.78 | 1.1 | 0.62 | 0.59 | |
Capex per share | -2.94 | -1.41 | -2.12 | -1.96 | -2.61 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
---|---|---|---|---|---|---|
Revenue per share | 7.21 | 7.71 | 7.68 | 7.33 | 9.24 | |
Net income per share | 1.06 | 1.61 | 2.04 | 1.42 | 1.96 | |
Operating cash flow per share | 0.91 | 2.43 | 1.66 | 1.82 | 0.7 | |
Free cash flow per share | 0.41 | 1.74 | 1.08 | 0.87 | -0.23 | |
Cash per share | 3.04 | 3.04 | 2.33 | 3.87 | 3.14 | |
Book value per share | 9.49 | 11.18 | 11.21 | 11.79 | 12.3 | |
Tangible book value per share | -3.03 | -0.94 | -0.53 | 0.14 | 0.19 | |
Share holders equity per share | 9.49 | 11.18 | 11.21 | 11.79 | 12.3 | |
Interest debt per share | 18.77 | 17.73 | 17.18 | 20 | 21.05 | |
Market cap | 290.8B | 328.89B | 357.68B | 322.18B | 415.45B | |
Enterprise value | 304.99B | 342.17B | 371.85B | 337.52B | 431.57B | |
P/E ratio | 76.33 | 56.64 | 46.15 | 59.89 | 58.91 | |
Price to sales ratio | 44.82 | 47.38 | 48.98 | 46.29 | 49.98 | |
POCF ratio | 354.34 | 150.54 | 226.42 | 186.17 | 657.45 | |
PFCF ratio | 786.59 | 210.21 | 349.26 | 389.53 | -2.03K | |
P/B Ratio | 34.03 | 32.66 | 33.59 | 28.79 | 37.55 | |
PTB ratio | 34.03 | 32.66 | 33.59 | 28.79 | 37.55 | |
EV to sales | 47.01 | 49.29 | 50.93 | 48.49 | 51.92 | |
Enterprise value over EBITDA | 146.61 | 142.44 | 155.4 | 198.07 | 186.03 | |
EV to operating cash flow | 371.63 | 156.61 | 235.39 | 195.03 | 682.97 | |
EV to free cash flow | 824.98 | 218.69 | 363.1 | 408.07 | -2.11K | |
Earnings yield | 0 | 0 | 0.01 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 1.97 | 1.58 | 1.52 | 1.69 | 1.7 | |
Debt to assets | 0.36 | 0.33 | 0.33 | 0.36 | 0.34 | |
Net debt to EBITDA | 6.82 | 5.52 | 5.92 | 9 | 6.95 | |
Current ratio | 1.1 | 1.13 | 1.05 | 1.3 | 1.13 | |
Interest coverage | 21.32 | 25.02 | 21.86 | 14.53 | 17.67 | |
Income quality | 0.86 | 1.5 | 0.82 | 1.29 | 0.36 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.93 | 0.61 | 0.46 | 0.76 | 0.58 | |
Sales general and administrative to revenue | 0.24 | 0.22 | 0.23 | 0.25 | 0.23 | |
Research and developement to revenue | 0.27 | 0.26 | 0.27 | 0.29 | 0.28 | |
Intangibles to total assets | 0.24 | 0.23 | 0.23 | 0.21 | 0.2 | |
Capex to operating cash flow | -0.55 | -0.28 | -0.35 | -0.52 | -1.32 | |
Capex to revenue | -0.07 | -0.09 | -0.08 | -0.13 | -0.1 | |
Capex to depreciation | -1.29 | -1.71 | -1.48 | -2.49 | -2.28 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | |
Graham number | 15.03 | 20.14 | 22.68 | 19.39 | 23.29 | |
ROIC | 0.06 | 0.07 | 0.06 | 0.04 | 0.06 | |
Return on tangible assets | 0.03 | 0.04 | 0.05 | 0.03 | 0.04 | |
Graham Net | -31.06 | -29.3 | -29.39 | -30.72 | -35.08 | |
Working capital | 1.49B | 1.99B | 896.3M | 4.8B | 2.42B | |
Tangible asset value | -2.73B | -849.8M | -504.2M | 134.7M | 166.9M | |
Net current asset value | -21.29B | -19.66B | -20.68B | -21.06B | -22.33B | |
Invested capital | 1.97 | 1.58 | 1.52 | 1.69 | 1.7 | |
Average receivables | 7.74B | 8B | 8.44B | 8.79B | 9.1B | |
Average payables | 1.55B | 1.67B | 1.81B | 1.97B | 2.25B | |
Average inventory | 3.9B | 3.87B | 4.07B | 4.43B | 4.67B | |
Days sales outstanding | 106.43 | 107.93 | 105.49 | 116.67 | 99.3 | |
Days payables outstanding | 104.39 | 95.93 | 112.24 | 111.53 | 123.2 | |
Days of inventory on hand | 245.33 | 218.35 | 250.55 | 251.45 | 238.95 | |
Receivables turnover | 0.85 | 0.83 | 0.85 | 0.77 | 0.91 | |
Payables turnover | 0.86 | 0.94 | 0.8 | 0.81 | 0.73 | |
Inventory turnover | 0.37 | 0.41 | 0.36 | 0.36 | 0.38 | |
ROE | 0.11 | 0.14 | 0.18 | 0.12 | 0.16 | |
Capex per share | -0.5 | -0.69 | -0.58 | -0.95 | -0.93 |
LLY.SW Frequently Asked Questions
What is Eli Lilly and Company stock symbol ?
Eli Lilly and Company is a US stock , located in Indianapolis of In and trading under the symbol LLY.SW
What is Eli Lilly and Company stock quote today ?
Eli Lilly and Company stock price is $490 today.
Is Eli Lilly and Company stock public?
Yes, Eli Lilly and Company is a publicly traded company.